BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zarrabian S, Riahi E, Karimi S, Razavi Y, Haghparast A. The potential role of the orexin reward system in future treatments for opioid drug abuse. Brain Research 2020;1731:146028. [DOI: 10.1016/j.brainres.2018.11.023] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Asakura S, Shiotani M, Gauvin DV, Fujiwara A, Ueno T, Bower N, Beuckmann CT, Moline M. Nonclinical evaluation of abuse liability of the dual orexin receptor antagonist lemborexant. Regul Toxicol Pharmacol 2021;127:105053. [PMID: 34619288 DOI: 10.1016/j.yrtph.2021.105053] [Reference Citation Analysis]
2 Kaufmann P, Ort M, Golor G, Kornberger R, Dingemanse J. First-in-human study with ACT-539313, a novel selective orexin-1 receptor antagonist. Br J Clin Pharmacol 2020;86:1377-86. [PMID: 32067262 DOI: 10.1111/bcp.14251] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
3 Rezaee L, Salehi S, Alizadeh A, Fazli-tabaei S, Haghparast A. Spinal Orexin-2 Receptors are Involved in Modulation of the Lateral Hypothalamic Stimulation-Induced Analgesia. Neurochem Res 2019;44:1152-8. [DOI: 10.1007/s11064-019-02749-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
4 James MH, Aston-Jones G. Introduction to the Special Issue: "Making orexin-based therapies for addiction a reality: What are the steps from here?". Brain Res 2020;1731:146665. [PMID: 31930996 DOI: 10.1016/j.brainres.2020.146665] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
5 Bjorness TE, Greene RW. Interaction between cocaine use and sleep behavior: A comprehensive review of cocaine's disrupting influence on sleep behavior and sleep disruptions influence on reward seeking. Pharmacol Biochem Behav 2021;206:173194. [PMID: 33940055 DOI: 10.1016/j.pbb.2021.173194] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Jamali S, Zarrabian S, Haghparast A. Similar role of mPFC orexin-1 receptors in the acquisition and expression of morphine- and food-induced conditioned place preference in male rats. Neuropharmacology 2021;198:108764. [PMID: 34450116 DOI: 10.1016/j.neuropharm.2021.108764] [Reference Citation Analysis]
7 Jacobson LH, Hoyer D, de Lecea L. Hypocretins (orexins): The ultimate translational neuropeptides. J Intern Med 2022. [PMID: 35043499 DOI: 10.1111/joim.13406] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Zammit G, Krystal A. Evaluating lemborexant for the treatment of insomnia. Expert Opin Pharmacother 2021;22:1235-43. [PMID: 33711243 DOI: 10.1080/14656566.2021.1902987] [Reference Citation Analysis]
9 McGregor R, Thannickal TC, Siegel JM. Pleasure, addiction, and hypocretin (orexin). Handb Clin Neurol 2021;180:359-74. [PMID: 34225941 DOI: 10.1016/B978-0-12-820107-7.00022-7] [Reference Citation Analysis]
10 Minbashi Moeini M, Sadr SS, Riahi E. Deep Brain Stimulation of the Lateral Hypothalamus Facilitates Extinction and Prevents Reinstatement of Morphine Place Preference in Rats. Neuromodulation 2021;24:240-7. [PMID: 33496024 DOI: 10.1111/ner.13320] [Reference Citation Analysis]
11 Jin N, Zhu SY, Yang XY, Zhen C, Li Y, Zhang HH, Xu AP, Wang MY, Zheng C. Orexin-A potentiates glycine currents by activating OX1R and IP3/Ca2+/PKC signaling pathways in spinal cord ventral horn neurons. Brain Res Bull 2021;169:196-204. [PMID: 33515654 DOI: 10.1016/j.brainresbull.2021.01.017] [Reference Citation Analysis]
12 Yu Y, He AB, Liou M, Ou C, Kozłowska A, Chen P, Huang AC. The Paradoxical Effect Hypothesis of Abused Drugs in a Rat Model of Chronic Morphine Administration. J Clin Med 2021;10:3197. [PMID: 34361981 DOI: 10.3390/jcm10153197] [Cited by in F6Publishing: 1] [Reference Citation Analysis]